Moderna Begins Testing COVID-19 Vaccine on Children
Moderna has given the first doses of its COVID-19 vaccine to children under the age of 12 — including babies as young as 6 months, the pharmaceutical company announced Tuesday.
The study is slated to enroll 6,750 healthy kids in the US and Canada and is the latest effort to include children in the global vaccination campaign.
Most of the US COVID-19 vaccination effort so far has focused on inoculating adults, who are at a higher risk of developing severe disease or dying from the virus.
Read More at the New York Post
